Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Biologics valuable treatment option for patients with inflammatory bowel disease

, the official journal of the American Gastroenterological Association (AGA) Institute. IBD includes Cro...

FDA Nanotechnology Task Force takes positive step forward

The Task Force is clear and candid in acknowledging the pervasive potential of nanotechnology to affect virtually every product category FDA regulates—from p...

A new century of Alzheimer's disease research

...

Support for Children's Health and Medicare Protection Act given to House leaders by ACP

Washington -- In a letter to leaders of the U.S. House of Representatives Ways and Means, and Energy and Commerce committees, the president of the American College of Physicians (ACP) today expressed support for the Children’s Health and Medicare Preotection (CHAMP) Act of 2007 (H.R. 3162). Representing 124,000 internal medicine physicians and medical student members, ACP is the largest medica...

White Blood Cell Booster May Help Cancer Patients Avoid Deadly Complications

DURHAM, N.C. -- Cancer patients who receive a drug that stimulates the growth of infection-fighting white blood cells may be significantly less likely to die from a chemotherapy-related complication characterized by fever and low white blood cell levels, according to a multi-institutional study led by researchers from the University of Rochester School of Medicine and Dentistry and the <A href...

Advanced therapy offers cure for relapsed cancer patient

About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses...

Researchers Discover How Cancer Evades the Immune System

A study on various kinds of cancer, conducted by researchers at the University of Southern California, has brought about the discovery of a new method to identify the genetic changes that enable tumours to evade the body's immune system. The findings, demonstrated in human breast and colorectal cancers, are significant to the field of medicine because they may lead to the advancem...

Structure of TB Enzyme Points the Way to New Drugs: Study

Swiss scientists said Monday that they have further evidence to suggest that an enzyme secreted by the microbe that causes tuberculosis would make a promising target for new drugs to combat the deadly infectious disease. The Swiss team first identified the enzyme, protein kinase G (PknG), as a promising drug target back in 2004. At the time, they said that the protein...

Singapore Dengue Cases Return to Epidemic Level

Dengue cases in affluent Singapore have reached 'epidemic' levels for the second time in the past month, health ministry data monitored Tuesday said. The Ministry of Health said 381 cases were reported between June 24 and 30, above the 'epidemic threshold' of 378 cases per week. Dengue cases crossed the threshold for the first time since 2005 earlier in June, when 401...

UN Calls for Pedal Power to Reduce Environmental Damage

More bicycle riding and other lifestyle changes are urgently needed to reduce climate-altering carbon emissions that are damaging Asia's health and could also threaten the economy, the World Health Organisation said Monday. Climate change contributes directly or indirectly to about 77,000 deaths per year in the region, according to WHO estimates. "So far the impact is...
[next]
(Date:5/16/2012)... issue of BioResearch Open Access , a ... today by Mary Ann Liebert, Inc., publishers. The ... broad range of scientific topics including but not ... and biomaterials, regenerative medicine, stem cells, gene therapy, ... The first issue is available on the ...
(Date:5/16/2012)... (HealthDay News) -- Heart palpitations and high blood pressure ... disorder called atrial fibrillation, a new study reports. ... stroke and death. It was already known that high ... but, according to the researchers, this is the first ... palpitations, which are commonly felt as a rapid or ...
(Date:5/16/2012)... myeloma patients are better equipped to halt progression of ... following a stem cell transplant, according to a study ... Science University Knight Cancer Institute. , The study, published ... found a 63 percent reduction in the risk of ... patients that were treated with lenalidomide maintenance therapy. , ...
(Date:5/15/2012)... Carina Storrs HealthDay Reporter , , TUESDAY, May ... to begin in London this summer, a new study ... an important public health message: Reducing air pollution levels ... Four years ago, an international team of ... the 2008 Olympics, to see what health effects those ...
(Date:5/15/2012)... (HealthDay News) -- Researchers have identified gene variants ... they say their findings could help identify patients ... The researchers, from the University of California-Los Angeles, ... develop new therapies. Parkinson,s disease is a ... rigidity. The researchers followed 233 patients for ...
Breaking Medicine News(10 mins):Health News:Premier issue of BioResearch Open Access launched by Mary Ann Liebert Inc. publishers 2Health News:Palpitations May Signal Future Heart Rhythm Problem 2Health News:Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant 2Health News:Beijing's Olympic Smog Shows Pollution's Effect on Health 2Health News:Beijing's Olympic Smog Shows Pollution's Effect on Health 3Health News:Genes Might Be Key to Parkinson's Spread 2
... the third phase of clinical trail conducted by researchers at ... weekly dose of erythropoietin //(EPO) is a very effective treatment ... ,EPO is a natural hormone that stimulates production ... cell (RBC) transfusions in these children. This is the ...
... in New York City has discovered that chronic pain occurs ... his colleagues were studying chronic pain at the molecular and ... occurs and the neurons becomes excited and begin to send ... when the stimulus is removed the nerves become dormant and ...
... exchange agreement with an Israeli company to introduce its ... technology enabled patients to be monitored anywhere and at ... telephones, Heartline Managing Director Dr Selva Annamalai told reporters ... doctor, 24 hours a day from anywhere, who could ...
... condition, chronic widespread pain is often difficult to ... depression and poor sleep.// ,A link between ... FM like symptoms after treatment with cytokine interleukin ... contradictory results. A new study published in the ...
... Cambodia in the Aids prevention initiatives have been applauded, ... of condoms.// ,Professor K. Satkunantham, the director of ... 100 per cent condom use programmes in Thailand and ... ,In the 25 years of the existence ...
... French teenage girl was admitted appearing unsteady and mentally sluggish ... doctors. // ,In addition it was found that the ... were puzzled because there appeared to be no family history ... in this week's New England Journal of Medicine. ...
Other Medicine News:Health News:EPO Effective For Cancer Patients Suffering From Anemia 2Health News:Insufficent Anti-inflammatoy Proteins Leads to Chronic Pain 2Health News:Teens High on Mothballs 2
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ... size and angle required for large and ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
Medicine Products:
(Date:5/15/2012)... -- PLC Systems Inc. (OTCBB: PLCSF), a company focused ... results for the three-month period ended March 31, ... operations, since PLC completed the sale of its ... the first quarter of 2011.  Results from the ... all periods presented. First quarter 2012 ...
(Date:5/15/2012)... 15, 2012 BiO2 Medical, Inc. a ... in San Antonio, Texas, and R&D and manufacturing ... has received CE Mark approval for the Angel™ ... permanently attached to a central venous catheter (CVC) ... in critically ill patients. This novel IVC filter/CVC ...
(Date:5/15/2012)... May 15, 2012  Boston Scientific Corporation ... the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium ... treating de novo coronary artery ... PROMUS Element™ Everolimus-Eluting Platinum Chromium Stent System ...  The trial reported one-year clinical and six-month ...
Breaking Medicine Technology:PLC Systems Reports First Quarter 2012 Results 2PLC Systems Reports First Quarter 2012 Results 3PLC Systems Reports First Quarter 2012 Results 4PLC Systems Reports First Quarter 2012 Results 5PLC Systems Reports First Quarter 2012 Results 6One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 2One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 3One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 4One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 5One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 6Cyberonics to Present at JMP Securities 4th Annual Healthcare Focus Conference 14268 1Cyberonics to Present at JMP Securities 4th Annual Healthcare Focus Conference 14268 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 1Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 10101 4Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 1Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 2Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 3Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 4Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 5Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 6Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 7Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 8Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 9Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 10Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 11Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 12Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 13Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 14Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 15Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 16Reportlinker Adds Whos Doing What in Molecular Diagnostics 3F Kalorama Emmes Survey of US Laboratories Report 58303 17
... Presented at International Conference on Malignant ... Shows Dose Dependent Single Agent Activity, BETHESDA, ... biopharmaceutical company developing novel, proprietary antibodies,for the treatment ... update of an ongoing phase 1 clinical trial ...
... Discuss Clinical, Financial ... DUBLIN, Ohio, June 4 In a move that ... of,hospital-acquired infections (HAIs), Cardinal Health announced today that,it will ... will focus on the leadership and operational issues that ...
Other Medicine Technology:Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 2Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 3Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 4Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 5Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 2Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 4